Oral Drug Shows Benefit for Notalgia Paresthetica in Mid-Stage Trial

(MedPage Today) -- A selective kappa opioid receptor agonist in patients with notalgia paresthetica led to "modestly" greater improvements in itchiness over placebo, but was associated with adverse events, a randomized phase II trial showed.
At...

Source: MedPage Today Dermatology - February 9, 2023 Category: Dermatology Source Type: news